Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer

CA Martey, SJ Pollock, CK Turner… - … of Physiology-Lung …, 2004 - journals.physiology.org
Cigarette smoking can lead to many human pathologies including cardiovascular and
respiratory disease. Recent studies have defined a role for fibroblasts in the development of …

Chemotherapy Induces the Expression of Cyclooxygenase-2 in Non–Small Cell Lung Cancer

NK Altorki, JL Port, F Zhang, D Golijanin, HT Thaler… - Clinical cancer …, 2005 - AACR
Purpose: To determine the effect of taxane-based chemotherapy on intratumoral levels of
cyclooxygenase-2 (COX-2) and prostaglandin E2 (PGE2) in patients with non–small cell …

COX-2 and its inhibition as a molecular target in the prevention and treatment of lung cancer

Z Liao, L Milas - Expert review of anticancer therapy, 2004 - Taylor & Francis
Lung cancer is the leading cause of cancer death in the USA. Conventional therapy using
chemotherapy, radiation therapy, and a combination of the two, has yielded modest …

[HTML][HTML] Transforming growth factor beta1 targets estrogen receptor signaling in bronchial epithelial cells

LC Smith, S Moreno, L Robertson, S Robinson… - Respiratory …, 2018 - Springer
Background Sex differences in idiopathic pulmonary fibrosis (IPF) suggest a protective role
for estrogen (E2); however, mechanistic studies in animal models have produced mixed …

COX-2 inhibitors suppress lung cancer cell growth by inducing p21 via COX-2 independent signals

SW Han, J Roman - Lung Cancer, 2006 - Elsevier
COX-2 has been implicated in the control of human non-small cell lung carcinoma (NSCLC)
cell growth. The mechanisms by which COX-2 exerts its mitogenic effects have not been …

Role of cyclooxygenase-2 in tumor progression and immune regulation in lung cancer

S Patel, S Chiplunkar - 2007 - nopr.niscpr.res.in
Lung cancer is the leading cause of cancer death all over the world. The low 5-year survival
rate (under 15%) has changed minimally in the last 25 years. Amongst different types of lung …

Cyclooxygenase-2 expression is abundant in alveolar type II cells in lung cancer-sensitive mouse strains and in premalignant lesions

SA Wardlaw, TH March, SA Belinsky - Carcinogenesis, 2000 - academic.oup.com
Abstract Overexpression of cyclooxygenase-2 (COX-2) is seen in a high percentage of
human colon tumors, lung adenocarcinomas and other cancers. Inhibition of this enzyme …

Hypoxia activates the cyclooxygenase-2–prostaglandin E synthase axis

JJ Lee, M Natsuizaka, S Ohashi, GS Wong… - …, 2010 - academic.oup.com
Abstract Hypoxia-inducible factors (HIFs), in particular HIF-1α, have been implicated in
tumor biology. However, HIF target genes in the esophageal tumor microenvironment …

COX-2 inhibition and lung cancer

AB Sandler, SM Dubinett - Seminars in oncology, 2004 - Elsevier
Cyclooxygenase-2 (COX-2) overexpression is seen in many malignancies including lung
cancer. In non-small cell lung cancer (NSCLC), COX-2 is overexpressed in most …

Epidermal growth factor receptor reactivation induced by E-prostanoid-3 receptor-and tumor necrosis factor-alpha-converting enzyme-dependent feedback …

S Kim, C Lewis, JA Nadel - Experimental Cell Research, 2011 - Elsevier
Airway epithelial cancer cells produce increased amounts of the chemokine interleukin-8 (IL-
8), inducing pro-tumor responses. Multiple stimuli induce airway epithelial IL-8 production …